首页|妊娠合并系统性红斑狼疮对妊娠结局和治疗影响的研究

妊娠合并系统性红斑狼疮对妊娠结局和治疗影响的研究

扫码查看
目的:探讨妊娠合并系统性红斑狼疮(Systemic Lupus Erythematosus,SLE)患者的临床特征,分析SLE对孕妇妊娠结局的影响.方法:选取2016年12月至2022年12月厦门大学附属中山医院妇产科收治的妊娠合并SLE患者92例作为研究组,选取正常妊娠孕妇71例作为对照组,比较两组基本信息、营养状态,比较研究组分娩前后用药情况,比较研究组孕妇妊娠不良结局.结果:研究组与对照组相比,两者年龄,妊娠次数,分娩次数无明显差异,既往不良孕产史差异明显(x2=6.457,P<0.05);研究组活动期白蛋白、血红蛋白明显下降(x2=2.473,P<0.05),(x2=3.767,P<0.05),但 BM1 值无明显差别(x2=6.457,P>0.05);研究组分娩后泼尼松口服、泼尼松龙静滴等使用明显增加(x2=3.115,P<0.05),(x2=5.572,P<0.05),而环磷酰胺静滴、羟氯喹口服等增加无统计学意义(x2=0.583,P>0.05),(x2=0.736,P>0.05),研究组活动期妊娠丢失,肺动脉高压(PE)等明显增加(x2=6.425 P<0.05),(x2=6.029,P<0.05),而产后出血无差异(x2=1.413,P>0.05).结论:妊娠合并SLE增加了孕妇不良孕产史,影响孕妇营养状态,限制了激素和免疫抑制剂的使用,妊娠合并SLE活动期增加了狼疮性肾炎等并发症,同时导致胎儿窘迫,早产等不良妊娠结局增多.本论文的研究结果可以为2023中国系统性红斑狼疮诊疗规范的后期标准制定提供借鉴内容.
Objective:Exploring the clinical characteristics of pregnant women with Systemic Lupus Erythematosus(SLE)and analyzing the impact of SLE on pregnancy outcomes.Method:92 pregnant women with combined SLE admitted to the Obstetrics and Gynecology Department of Zhongshan Hospital Affiliated to Xiamen University from December 2016 to December 2022 were selected as the study group,and 71 normal pregnant women were selected as the control group.The basic information and nutritional status of the two groups were compared,and the medication situation before and after delivery for pregnant women with combined SLE inthestudygroupwas compared.Results:The adverse pregnancy outcomes of the study group were also compared.Compared with the control group,there was no significant difference in age,number of pregnancies,and number of deliveries between the study group and the control group.However,there was a significant difference in the history of adverse pregnancy and childbirth between the two groups(x2=6.457,P<0.05);During the active period of the study group,there was a significant decrease in albumin and hemoglobin levels(x2=2.473,P<0.05)(x2=3.767,P<0.05),but there was no significant difference in BMI values(x2=6.457,P>0.05);There is a significant increase in the use of oral prednisone and intravenous prednisolone after delivery in pregnancy with SLE(x2=3.115,P<0.05)(x2=5.572,P<0.05),while the increase in intravenous cyclophosphamide and oral hydroxychloroquine was not statistically significant(x2=0.583,P>0.05)(x2=0.736,P>0.05).In the study group,there was a significant increase in active pregnancy loss and pulmonary hypertension(PE)(x2=6.425 P<0.05),(x2=6.029,P<0.05),but there was no difference in postpartum hemorrhage(x2=1.413,P>0.05).Conclusion:Pregnancy combined with SLE increases the adverse pregnancy history of pregnant women,affects their nutritional status,limits the use of hormones and immunosuppressants,increases complications such as lupus nephritis during active phase of pregnancy combined with SLE,and leads to increased adverse pregnancy outcomes such as fetal distress and premature birth.The research results of this paper can provide reference content for the later development of diagnostic and treatment standards for systemic lupus erythematosus in China in 2023.

PregnancySystemic lupus erythematosusComplicationsNutritionMedicationsAdverse pregnancy outcomes

田丽莉、吴琼、阮雪茹

展开 >

厦门大学附属中山医院·福建厦门 361004

妊娠 系统性红斑狼疮 并发症 营养 药物 妊娠不良结局

2023

黑龙江中医药
黑龙江省中医研究院

黑龙江中医药

影响因子:0.425
ISSN:1000-9906
年,卷(期):2023.52(6)
  • 13